(R)-tert-Butyl 2-(hydroxymethyl)piperazine-1-carboxylate

Catalog No. :
ACCFOB698
CAS No. :
169448-87-7
Molecular Formula :
C10H20N2O3
Molecular Weight :
216.28

IUPAC Name:tert-butyl (R)-2-(hydroxymethyl)piperazine-1-carboxylate

(R)-tert-Butyl 2-(hydroxymethyl)piperazine-1-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
5g97%$69.00Login to see priceIn stockInquiry
10g97%$135.00Login to see priceIn stockIn stock
25g97%$314.00Login to see priceIn stockIn stock
100g97%$940.00Login to see priceIn stockIn stock

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(R)-tert-Butyl 2-(hydroxymethyl)piperazine-1-carboxylate
IUPAC Nametert-butyl (R)-2-(hydroxymethyl)piperazine-1-carboxylate
MDL No.MFCD07772092
Molecular FormulaC10H20N2O3
Molecular Weight216.28
SMILESOC[C@@H]1N(C(OC(C)(C)C)=O)CCNC1
InChI KeyBCPPNDHZUPIXJM-MRVPVSSYSA-N
Synonym169448-87-7 | (R)-1-Boc-2-Hydroxymethyl-piperazine | (R)-1-Boc-2-Hydroxymethylpiperazine | (R)-tert-butyl 2-(hydroxymethyl)piperazine-1-carboxylate | tert-butyl (2R)-2-(hydroxymethyl)piperazine-1-carboxylate | (R)-1-Boc-2-(Hydroxymethyl)piperazine | (R)-1-N-BOC-2-HYD
CAS No.169448-87-7
PubChem CID24820219

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H332-H335
Precautionary Statement(s)
P261-P280-P305+P351+P338

Synthetic Route by SureRoute

1. ACCFOB698 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACCFOB698 route product structure diagram
    ACCFOB698169448-87-7 In Stock
Inquiry

2. ACCFOB698 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACPEKS641 route compound structure diagram
    ACPEKS641930782-89-1 In Stock
  2. Then
  3. ACCFOB698 route product structure diagram
    ACCFOB698169448-87-7 In Stock
Inquiry

Comments (0)